Mobile Apps as Medical Devices

The rapid expansion and broad applicability of software functions / applications deployed on mobile or other general-purpose computing platforms has created concerns with industry and the US FDA. This has resulted in the FDA focusing on the subset of software functions dealing with medical issues which the Agency intends to apply its authority. What are these issues / software app claims, and how will this affect the medical device industry.

$999.00
Introducing
Purchase using Webinar All-Access Pass
One user get unlimited access to all upcoming and recorded webinars for one year (350+)

Recorded Version Only

(PPT + Recorded Streaming Link)

$299.00
1x Person - Unlimited viewing for 6 Months (For multiple locations contact Customer Care)
rec Recorded Link and Ref. material will be available in My Account Section
Last Recorded Date: Jul-2021

CD or USB Drive Only

(PPT + Recorded Training File)

$399.00
One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days
Customer Care

Fax: +1-650-362-2367

Email: customercare@fdatrainingalert.com

Follow us:
Why Should You Attend:

FDA refers to software functions that are device functions as “device software functions.”

These may include “Software as a Medical Device (SaMD)” and “Software in a Medical Device (SiMD)”. If a software function that meets the definition of a device is deployed on a mobile platform, it may be referred to as a “mobile medical app.”

These new technologies use terms such as “mobile medical apps,” “mobile medical app manufacturers,” “device software functions,” and “device software function manufacturers”, and are always not specific to whether the function is deployed on a mobile platform or other general purpose-computing platform.

What are the FDA definitions and regulatory expectations? What is also required for effective and real world software verification and validation in such use environments? This discussion will focus on what is and what is not recognized as a Mobile Apps for regulation as a medical device by the US FDA. Cybersecurity, CGMP, 21 CFR Part 11 and submission considerations will be discussed as well.

Some of these new mobile apps / software functions are specifically targeted to assisting individuals in their own health and wellness management. Others are targeted to health care providers as tools to improve and facilitate the delivery of patient care. These software devices include products that feature one or more software components, parts, or accessories, as well as devices that are composed solely of software.

Certain software functions / mobile apps that are device functions can pose potential risks to public health, and these are the subject of FDA concern and focused regulation.

Mobile medical apps, as defined here, include only those mobile apps that: Meet the definition of a device; and either are Intended to be used as an accessory to a regulated medical device; or are Intended to transform a mobile platform into a regulated medical device. What are they as defined by the FDA, what are not? Requirements? Cybersecurity concerns, validation and documentation requirements will also be addressed.

Areas Covered in the Webinar:
  • Mobile Health Apps / Functions – What are they?
  • SaMD and SiMD
  • FDA’s Functionality vs. Platform enforcement approach
  • Intended Use – not just a term
  • Software functions that are, or are NOT, a “device”
  • FDA’s regulatory approach; Examples
  • Design, manufacturing and additional requirements
  • Cybersecurity requirements
  • Validation and unique documentation requirements
Who Will Benefit:
  • Senior management in Devices, Combination Products
  • QA / RA
  • Software development, programming, documentation, testing teams
  • R&D
  • Engineering
  • Production
  • Operations
  • Marketing
  • Consultants; others tasked with product, process, electronic records software V&V responsibilities
Instructor Profile:
John E Lincoln John E Lincoln

Principal, J E Lincoln and Associates

John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 36 years’ experience in U.S. FDA-regulated industries, 22 as a full-time consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D). In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, conducted workshops and webinars worldwide on CAPA, 510(k)s, risk analysis / management, FDA / GMP audits, validation, root cause analysis, and others. John is a graduate of UCLA.

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

You Recently Viewed